Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study (vol 8, e000331, 2020)

被引：0
|
作者：
Najjar, Y. G.
Navrazhina, K.
Ding, F.
Puzanov, Igor
机构：
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷 / 02期
关键词：
D O I：
10.1136/jitc-2019-000331corr1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Efficacy and Safety of Nivolumab and Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study
    Iinuma, Koji
    Kameyama, Koji
    Kawada, Kei
    Fujimoto, Shota
    Takagi, Kimiaki
    Nagai, Shingo
    Ito, Hiroki
    Ishida, Takashi
    Kawase, Makoto
    Kawase, Kota
    Nakai, Chie
    Kato, Daiki
    Takai, Manabu
    Nakane, Keita
    Koie, Takuya
    CURRENT ONCOLOGY, 2021, 28 (02) : 1402 - 1411
  • [32] Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma (vol 2, pg 632, 2014)
    Hodi, F. S.
    Lawrence, D.
    Lezcano, C.
    Wu, X.
    Zhou, J.
    Sasada, T.
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (09) : 923 - 923
  • [33] CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
    Janjigian, Yelena Y.
    Bendell, Johanna
    Calvo, Emiliano
    Kim, Joseph W.
    Ascierto, Paolo A.
    Sharma, Padmanee
    Ott, Patrick A.
    Peltola, Katriina
    Jaeger, Dirk
    Evans, Jeffry
    de Braud, Filippo
    Chau, Ian
    Harbison, Christopher T.
    Dorange, Cecile
    Tschaika, Marina
    Le, Dung T.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (28) : 2836 - +
  • [34] Real-World Oncological Outcomes of Nivolumab Plus Ipilimumab in Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study in Japan
    Taniguchi, Tomoki
    Iinuma, Koji
    Kawada, Kei
    Ishida, Takashi
    Takagi, Kimiaki
    Tomioka, Masayuki
    Kawase, Makoto
    Kawase, Kota
    Nakane, Keita
    Tobisawa, Yuki
    Koie, Takuya
    CURRENT ONCOLOGY, 2024, 31 (12) : 7914 - 7923
  • [35] Treosulfan and gemcitabine in metastatic uveal melanoma patients:: results of a multicenter feasibility study
    Pföhler, C
    Cree, IA
    Ugurel, S
    Kuwert, C
    Haass, N
    Neuber, K
    Hengge, U
    Corrie, PG
    Zutt, M
    Tilgen, W
    Reinhold, U
    ANTI-CANCER DRUGS, 2003, 14 (05) : 337 - 340
  • [36] Multicenter retrospective analysis of patients with metastatic renal cell carcinoma (mRCC) and bone metastases treated with ipilimumab and nivolumab
    Desai, Kunal
    Brown, Landon Carter
    Wei, Wei
    Allman, Kimberly D.
    Martin, Allison
    Wood, Laura S.
    Gupta, Shilpa
    Gilligan, Timothy D.
    Garcia, Jorge A.
    Kao, Chester
    Kinsey, Emily Noelle
    Healy, Patrick
    Kephart, Julie
    Harrison, Michael Roger
    Ramalingam, Sundhar
    Armstrong, Andrew J.
    George, Daniel J.
    Rini, Brian I.
    Zhang, Tian
    Ornstein, Moshe Chaim
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [37] Nivolumab plus ipilimumab in advanced hepatocellular carcinoma with Child-Pugh B: A multicenter retrospective study.
    Kim, Jung Sun
    Kim, Youngun
    Kim, Hyeyeong
    Kang, Beodeul
    An, Chansik
    Kim, Ilhwan
    Kim, Chan
    Chon, Hong Jae
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 551 - 551
  • [38] Retrospective study of advanced melanoma patients treated with ipilimumab after nivolumab: Analysis of 60 Japanese patients
    Fujisawa, Yasuhiro
    Yoshino, Koji
    Otsuka, Atsushi
    Funakoshi, Takeru
    Uchi, Hiroshi
    Fujimura, Taku
    Matsushita, Shigeto
    Hata, Hiroo
    Okuhira, Hisako
    Tanaka, Ryota
    Nagai, Kojiro
    Ishida, Yoshihiro
    Nakamura, Yoshio
    Furudate, Sadanori
    Yamamura, Kentaro
    Imafuku, Keisuke
    Yamamoto, Yuki
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2018, 89 (01) : 60 - 66
  • [39] A multicenter phase II study of nivolumab plus /- ipilimumab for patients with metastatic sarcoma (Alliance A091401): Results of expansion cohorts.
    Chen, James Lin
    Mahoney, Michelle R.
    George, Suzanne
    Antonescu, Cristina R.
    Liebner, David A.
    Van Tine, Brian Andrew
    Milhem, Mohammed M.
    Tap, William D.
    Streicher, Howard
    Schwartz, Gary K.
    D'Angelo, Sandra P.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer (vol 36, pg 2836, 2018)
    Janjigian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (05) : 443 - 443
12345